Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Articles
Who Should Be Screened for Tumor Mutations?
Interview with the Innovators
Videos
Featuring:
Ezra Cohen, MD, FRCPSC, FASCO
Professor of Medicine
Chief
Division of Hematology/Oncology
UC San Diego
La Jolla, CA
Mary Jo Fidler, MD
Associate Professor and Section Chief
Medical Oncology
Rush University Medical Center
Chicago, IL
Arturo Loaiza-Bonilla, MD, MSEd, FACP
Enterprise Medical Director of Research
Comprehensive Care and Research Center
Philadelphia, PA
Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler of Rush University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, examine who should be tested for tumor mutations.
Related Articles
Relapsed or Refractory FL: Best Practices for Active Surveillance & Reinforcement of Management Plans
By
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
Interview with the Innovators
Videos
Read Article
Predicting High-Risk Disease Using Progression of Disease in 24 Months (POD24) and the Key Role of Repeat Biopsy to Exclude the Diagnosis of Transformation to a High-Grade Lymphoma in Patients with Relapsed Follicular Lymphoma
By
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
Interview with the Innovators
Videos
Read Article
Broadening the Variety of Candidate Therapies for R/R Follicular Lymphoma Allows Optimal Personalized Rx Choice, While Patient-Directed Education Helps Attain Greatest Clinical Benefit
By
Tycel J. Phillips, MD
;
Peg Rummel, MHA, RN, OCN, NE-BC
;
Andrew D. Zelenetz, MD, PhD
Interview with the Innovators
Videos
Read Article
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Addressing Cancer Health Disparities: The No One Left Alone Initiative
Rohan Nathwani
,
Arva Patel
,
Warner Kornberg
,
Asutosh Gor, MD
,
Sashi Naidu, MD
,
Viral Rabara, MD
,
Niyati Nathwani, MD
,
Kashyap Patel, MD
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
Talvey Receives Accelerated Approval for Relapsed or Refractory Multiple Myeloma
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma